Epiconcept provides technical support on implementation of a COVID-19 and influenza vaccine effectiveness (VE) networks for the WHO European Region, WHO Regional Office for Africa, and WHO Regional Office for the Eeastern Mediterranean Region including collection, collation and analysis of country level health care worker (HCW) VE and Severe Acute Respiratory Infection (SARI) VE studies; and support to WHO Europe in the meta-analysis and pooling of SARI and HCW VE studies for the WHO Region
Following the rollout of COVID-19 vaccines, it was key to monitor their effectiveness in different settings, including low and middle income countries. Vaccine effectiveness results are essential to guide vaccination policies.
Development of generic vaccine effectiveness protocols.
Epiconcept developed two generic protocols to measure the effectiveness of vaccines 1/ at preventing SARS-CoV-2-associated hospitalisation (test-negative design) 2/ SARS-CoV-2 symptomatic infections among health care workers (cohort study)
Technical support to countries conducting vaccine effectiveness studies
Technical support to collect, collate and analysis of country level health care worker (HCW) vaccine effectiveness studies and Severe Acute Respiratory Infection (SARI) vaccine effectiveness studies
Pooling and aggregation of data at regional level
Support the three WHO Regional Offices in the meta-analysis and pooling of SARI and HCW VE studies
Capacity building for vaccine effectiveness studies
Organise technical workshops, trainings, develop scripts for data management, data checking and data analysis for countries conducting vaccine effectiveness studies